|
|
||||||||
American Journal of Clinical Nutrition, Vol 63, 130-137, Copyright © 1996 by The American Society for Clinical Nutrition, Inc
ORIGINAL RESEARCH COMMUNICATIONS |
EJ Kasarskis, S Berryman, JG Vanderleest, AR Schneider and CJ McClain
Department of Neurology, University of Kentucky, Lexington, USA.
Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disease characterized by progressive muscle atrophy and weakness. Although dysphagia is a universal feature of this illness, the nutritional and metabolic status of ALS patients has received little attention. We performed serial measurements of muscle power, body composition, energy expenditure, nitrogen balance, and dietary intake on ALS patients on three occasions over 6 mo in the General Clinical Research Center of the University of Kentucky Medical Center. Data were analyzed in reference to the time of death. Regression analysis demonstrated progressive decreases in body fat, lean body mass, muscle power, and nitrogen balance and an increase in resting energy expenditure as death approached. The changes in body composition were greater in males. Energy and protein consumption averaged 84% and 126% of the recommended dietary allowances, respectively, but did not correlate with complaints of dysphagia. We conclude that ALS patients have a chronically deficient intake of energy and recommended augmentation of energy intake rather than the consumption of high- protein nutritional supplements.
This article has been cited by other articles:
![]() |
S. M. Albert Dyslipidemia in ALS: Good, bad, or unclear? Neurology, March 25, 2008; 70(13): 988 - 989. [Full Text] [PDF] |
||||
![]() |
L. Dupuis, P. Corcia, A. Fergani, J. -L. Gonzalez De Aguilar, D. Bonnefont-Rousselot, R. Bittar, D. Seilhean, J. -J. Hauw, L. Lacomblez, J. -P. Loeffler, et al. Dyslipidemia is a protective factor in amyotrophic lateral sclerosis Neurology, March 25, 2008; 70(13): 1004 - 1009. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. J McDermott and P. J Shaw Diagnosis and management of motor neurone disease BMJ, March 22, 2008; 336(7645): 658 - 662. [Full Text] [PDF] |
||||
![]() |
L. Ferraiuolo, P. R. Heath, H. Holden, P. Kasher, J. Kirby, and P. J. Shaw Microarray Analysis of the Cellular Pathways Involved in the Adaptation to and Progression of Motor Neuron Injury in the SOD1 G93A Mouse Model of Familial ALS J. Neurosci., August 22, 2007; 27(34): 9201 - 9219. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Fergani, H. Oudart, J.-L. Gonzalez De Aguilar, B. Fricker, F. Rene, J.-F. Hocquette, V. Meininger, L. Dupuis, and J.-P. Loeffler Increased peripheral lipid clearance in an animal model of amyotrophic lateral sclerosis J. Lipid Res., July 1, 2007; 48(7): 1571 - 1580. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. S. Sherman, A. Pillai, A. Jackson, and T. Heiman-Patterson Standard Equations Are Not Accurate in Assessing Resting Energy Expenditure in Patients With Amyotrophic Lateral Sclerosis JPEN J Parenter Enteral Nutr, November 1, 2004; 28(6): 442 - 446. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. S. Shaw, M. A. Ampong, A. Rio, J. McClure, P. N. Leigh, and P. S. Sidhu Entristar Skin-Level Gastrostomy Tube: Primary Placement with Radiologic Guidance in Patients with Amyotrophic Lateral Sclerosis Radiology, November 1, 2004; 233(2): 392 - 399. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Dupuis, H. Oudart, F. Rene, J.-L. G. de Aguilar, and J.-P. Loeffler Evidence for defective energy homeostasis in amyotrophic lateral sclerosis: Benefit of a high-energy diet in a transgenic mouse model PNAS, July 27, 2004; 101(30): 11159 - 11164. [Abstract] [Full Text] [PDF] |
||||
![]() |
P N Leigh, S Abrahams, A Al-Chalabi, M-A Ampong, L H Goldstein, J Johnson, R Lyall, J Moxham, N Mustfa, A Rio, et al. The management of motor neurone disease J. Neurol. Neurosurg. Psychiatry, December 1, 2003; 74(90004): iv32 - 47. [Full Text] [PDF] |
||||
![]() |
J. C Desport, P. M Preux, C. Bouteloup-Demange, P. Clavelou, B. Beaufrere, C. Bonnet, and P. P Couratier Validation of bioelectrical impedance analysis in patients with amyotrophic lateral sclerosis Am. J. Clinical Nutrition, May 1, 2003; 77(5): 1179 - 1185. [Abstract] [Full Text] [PDF] |
||||
![]() |
R S Howard and R W Orrell Management of motor neurone disease Postgrad. Med. J., December 1, 2002; 78(926): 736 - 741. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. C Desport, P. M Preux, L. Magy, Y. Boirie, J. M Vallat, and B. Beaufrere Factors correlated with hypermetabolism in patients with amyotrophic lateral sclerosis Am. J. Clinical Nutrition, September 1, 2001; 74(3): 328 - 334. [Abstract] [Full Text] |
||||
![]() |
N. Lechtzin, C. M. Wiener, L. Clawson, V. Chaudhry, and G. B. Diette Hospitalization in amyotrophic lateral sclerosis: Causes, costs, and outcomes Neurology, March 27, 2001; 56(6): 753 - 757. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. C. Desport, P. M. Preux, T. C. Truong, J. M. Vallat, D. Sautereau, and P. Couratier Nutritional status is a prognostic factor for survival in ALS patients Neurology, September 1, 1999; 53(5): 1059 - 1059. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. G. Miller, J. A. Rosenberg, D. E. Gelinas, H. Mitsumoto, D. Newman, R. L. Sufit, G. D. Borasio, W. G. Bradley, M. B. Bromberg, B. R. Brooks, et al. Practice Parameter: The Care of the Patient with Amyotrophic Lateral Sclerosis (An Evidence-Based Review): Report of the Quality Standards Subcommittee of the American Academy of Neurology Neurorehabil Neural Repair, June 1, 1999; 13(2): 93 - 107. [PDF] |
||||
![]() |
R. G. Miller, J. A. Rosenberg, D. F. Gelinas, H. Mitsumoto, D. Newman, R. Sufit, G. D. Borasio, W. G. Bradley, M. B. Bromberg, B. R. Brooks, et al. Practice parameter: The care of the patient with amyotrophic lateral sclerosis (an evidence-based review): Report of the Quality Standards Subcommittee of the American Academy of Neurology Neurology, April 1, 1999; 52(7): 1311 - 1311. [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |